CI

The Cigna Group

CIHealthcareNASDAQ

Healthcare Plans · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$273.85B
+11.3% YoY
Net Income
$5.96B
+73.5% YoY
EBITDA
$11.96B
+26.2% YoY
Free Cash Flow
$6.92B

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Positive CrossoverHistogram +1.1135, positive momentum
Jul 10 MACD Positive CrossoverHistogram +0.8518, positive momentum
About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. At a $74.45B market cap, The Cigna Group ranks as a large-cap company within healthcare. It operates through two segments: Evernorth Health Services and Cigna Healthcare.

Key stats
Market Cap$74.45B
P/E (TTM)12.03
Fwd P/E8.41
EPS$23.39
Beta0.30
52W Change-4.8%
Dividend Yield2.20%
ROE16.3%
Analysis

On the balance sheet, CI has $7.85B in cash with $30.90B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $6.92B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 16.3%, which is strong for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.8% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $179.36B (2022) to $273.85B (2025), reflecting a 53% increase over the period.

With a beta below 0.7, The Cigna Group typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. No single metric tells the full story. Reviewing CI's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms